Charles Larry Bisgaier

Title: The Innovations of Charles Larry Bisgaier

Introduction

Charles Larry Bisgaier is a prominent inventor based in Ann Arbor, MI, known for his significant contributions to the field of cardiovascular health. With a total of 17 patents to his name, Bisgaier has focused on developing methods and treatments that aim to reduce the risk of cardiovascular diseases and improve patient outcomes.

Latest Patents

Among his latest patents are innovative methods for reducing the risk of cardiovascular disease. These include techniques for lowering plasma LDL-C levels in patients on a stable dose of statins, particularly those with LDL-C levels above treatment goals. He has also developed methods aimed at decreasing a patient's risk for developing coronary heart disease and managing recurrent cardiovascular events. Additionally, his work on the treatment of Non-Alcoholic Steatohepatitis (NASH) with Gemcabene includes methods and formulations designed to reduce elevated lipid levels in subjects with type IIb hyperlipidemia. His patents also cover methods for preventing complications associated with lipid disorders, including NASH and Non-Alcoholic Fatty Liver Disease (NAFLD), as well as kits useful for these methods.

Career Highlights

Throughout his career, Bisgaier has worked with notable companies such as Warner-Lambert Company and Esperion Therapeutics, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Paul Leroy Creger and Alan Robert Saltiel. Their collaborations have further advanced the research and innovations in cardiovascular health.

Conclusion

Charles Larry Bisgaier's work has made a significant impact on the field of cardiovascular medicine through his numerous patents and innovative methods. His dedication to improving patient health outcomes continues to inspire advancements in medical research.